Markets » Mutual Funds » Asset Allocation

Nippon India Pharma Fund - Direct (Bonus) - Scheme Profile

Fund

Fund House : Nippon India Mutual Fund

Fund Class : Equity - Pharma

NAV 04 Aug 2021 336.96 -2.28
(-0.67%)

Asset Type

Asset Allocation
Cash & Cash Equivalent 0.00
Derivatives 0.17
Equity 99.31
Reverse Repo 2.35
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Dr Reddy's Labs Pharmaceuticals - Indian - Bulk Drugs & Fo... 960,000 520.61 9.56 -7.47
Divi's Lab. Pharmaceuticals - Indian - Bulk Drugs 1,150,000 506.95 9.31 21.93
Sun Pharma.Inds. Pharmaceuticals - Indian - Bulk Drugs & Fo... 7,300,976 493.14 9.05 15.03
Cipla Pharmaceuticals - Indian - Bulk Drugs & Fo... 4,800,000 466.51 8.56 6.4
Aurobindo Pharma Pharmaceuticals - Indian - Bulk Drugs & Fo... 4,500,000 434.34 7.97 -10.57
Lupin Pharmaceuticals - Indian - Bulk Drugs 3,400,025 390.70 7.17 -4.58
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Chemicals 0.87
Healthcare 20.43
NA 2.52
Pharmaceuticals - Indian - Bulk Drugs 26.79
Pharmaceuticals - Indian - Bulk Drugs & Formln 45.82
Pharmaceuticals - Multinational 5.40

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 2.76
Alkem Lab 0.47
Apollo Hospitals 4.60
Aurobindo Pharma 7.97
Biocon 0.02
Cadila Health. 4.74
Cipla 8.56
Divi's Lab. 9.31
.